Cargando…
Current status of multimodal & combination therapy for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. Surgery offers the only hope for cure. However, the potentially curable method is only possible for a small proportion of those afflicted, for the rest, palliative treatment is indicated. Despite all the treatment options w...
Autores principales: | Yang, Jian, Yan, Lunan, Wang, Wentao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510885/ https://www.ncbi.nlm.nih.gov/pubmed/23041732 |
Ejemplares similares
-
Current Status of Gene Therapy in Hepatocellular Carcinoma
por: Reghupaty, Saranya Chidambaranathan, et al.
Publicado: (2019) -
Current status and prospect of treatments for recurrent hepatocellular carcinoma
por: Yang, Yu-Qing, et al.
Publicado: (2023) -
Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma
por: Jianyong, Lei, et al.
Publicado: (2017) -
The Current Status and Future Prospects for Conversion Therapy in the
Treatment of Hepatocellular Carcinoma
por: Bai, Jinfeng, et al.
Publicado: (2023) -
Multimodal Molecular Imaging: Current Status and Future Directions
por: Wu, Min, et al.
Publicado: (2018)